Proficio Capital Partners LLC Exelixis, Inc. Transaction History

Proficio Capital Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$17.68 - $22.65 $4,561 - $5,843	-258 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$18.93 - $24.75 $1,627 - $2,128	86 Added 50.0%	258 $6,000
Q1 2019 May 13, 2019	BUY	$19.6 - $24.76 $1,097 - $1,386	56 Added 48.28%	172 $4,000
Q4 2018 Feb 08, 2019	BUY	$13.65 - $21.8 $1,583 - $2,528	116 New	116 $2,000
Q3 2018 Nov 13, 2018	SELL	$15.87 - $22.4 $2,904 - $4,099	-183 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$18.56 - $22.45 $18 - $22	1 Added 0.55%	183 $4,000
Q1 2018 May 14, 2018	BUY	$22.15 - $31.89 $3,654 - $5,261	165 Added 970.59%	182 $4,000
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $411 - $525	17	17 $1,000

507

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.